COVID-19 Vaccine Trial Volunteer in India Develops Encephalopathy and Sues
A 40-year old business consultant in India, who volunteered to be a participant in clinical trials of the experimental COVID-19 vaccine (Covishield) created by AstraZeneca and Oxford University is suing Serum Institute of India (SII), which is producing the vaccine in India, for 50 million rupees ($680,000) after he developed acute encephalopathy (brain dysfunction) within […]
Merck is Sued for Injuries Caused by Gardasil
Sahara Walker was only 11 years old in 2013 when she received the Gardasil vaccine that drastically changed her life, according to the attorneys who filed a lawsuit in U.S. District Court for the Western District of Wisconsin against the New Jersey based pharmaceutical giant, Merck on Nov. 18, 2020. Prior to Gardasil, Sahara was […]
Government Proposes Making It Harder to Get Vaccine Injury Compensation
In July 2020, the U.S. Department of Health and Human Services (HHS) published a notice of proposed rule making in the Federal Register1 that would remove shoulder injuries and vasovagal syncope from the Vaccine Injury Table used by the National Vaccine Injury Compensation Program (NVICP). The proposed rule making would also eliminate Item XVII, whereby […]
Denmark Citizens Refuse Law Mandating Forced COVID-19 Vaccine
With a COVID-19 vaccine possibly rolling out to the public by December or early next year, some governments are pushing for a mandatory vaccine program, as in Denmark where it was met with protests. The national government in Denmark had to abandon a new law that would require a mandatory COVID-19 vaccine after Danish citizens took to the streets […]
Pfizer CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced
Story Highlights On Nov. 9, 2020, Pfizer released preliminary Phase 3 clinical trial data indicating that its experimental mRNA COVID-19 vaccine is 90 percent effective, triggering a big surge in stock price. Pfizer CEO Albert Bourla immediately sold 60 percent of his company stock, realizing a gain of $5.6 million in what the company called […]
Another Shot at a Vaccine for Lyme Disease
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]